Risk Factors for Community- and Workplace Transmission of COVID-19
Launched by OSLO UNIVERSITY HOSPITAL · Mar 23, 2020
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how COVID-19 spreads in both communities and workplaces. Researchers want to understand the different factors that might increase the risk of getting or spreading the virus. To do this, they will use an electronic questionnaire that participants will fill out, sharing information about their experiences and environments during the pandemic.
To be part of this study, you need to be a Norwegian adult aged 18 or older and able to give your consent. There is no specific upper age limit, so anyone within this age range can participate. If you join, you will complete the questionnaire, which will help researchers gather important information on COVID-19 transmission. This study is currently looking for volunteers, and your input could help improve understanding and prevention efforts related to COVID-19.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Norwegian adult
- Exclusion Criteria:
- • Unable to consent
About Oslo University Hospital
Oslo University Hospital is a leading academic medical center in Norway, renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, the hospital integrates cutting-edge scientific inquiry with patient care, fostering an environment that promotes the development of new therapies and treatment strategies. With a multidisciplinary approach, Oslo University Hospital collaborates with various stakeholders, including researchers, healthcare professionals, and industry partners, to enhance clinical outcomes and contribute to the global medical community. Its dedication to ethical standards and patient safety ensures that all trials are conducted with the highest level of integrity and respect for participant welfare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Oslo, , Norway
Oslo, , Norway
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials